The pathogenesis of NIDDM involves a defective expression of the GIP receptor

被引:90
作者
Holst, JJ
Gromada, J
Nauck, MA
机构
[1] NOVO NORDISK AS, DEPT ISLET CELL PHYSIOL, COPENHAGEN, DENMARK
[2] RUHR UNIV BOCHUM, KNAPPSCHAFTS KRANKENHAUS, DEPT MED, D-4630 BOCHUM, GERMANY
关键词
D O I
10.1007/s001250050779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:984 / 986
页数:3
相关论文
共 34 条
[1]  
BROWN JC, 1994, GUT PEPTIDES BIOCH P, P765
[2]   Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients [J].
Creutzfeldt, WOC ;
Orskov, C ;
Kleine, N ;
Holst, JJ ;
Willms, B ;
Nauck, MA .
DIABETES CARE, 1996, 19 (06) :580-586
[3]   BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].
DEACON, CF ;
NAUCK, MA ;
TOFTNIELSEN, M ;
PRIDAL, L ;
WILLMS, B ;
HOLST, JJ .
DIABETES, 1995, 44 (09) :1126-1131
[4]   Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide [J].
Ding, WG ;
Gromada, J .
DIABETES, 1997, 46 (04) :615-621
[5]   THE INSULINOTROPIC ACTIONS OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE-1(7-37) IN NORMAL AND DIABETIC SUBJECTS [J].
ELAHI, D ;
MCALOONDYKE, M ;
FUKAGAWA, NK ;
MENEILLY, GS ;
SCLATER, AL ;
MINAKER, KL ;
HABENER, JF ;
ANDERSEN, DK .
REGULATORY PEPTIDES, 1994, 51 (01) :63-74
[6]   CELL AND MOLECULAR-BIOLOGY OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-I AND GLUCOSE-DEPENDENT INSULIN RELEASING POLYPEPTIDE [J].
FEHMANN, HC ;
GOKE, R ;
GOKE, B .
ENDOCRINE REVIEWS, 1995, 16 (03) :390-410
[7]   CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION OF THE HUMAN PANCREATIC-ISLET GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR [J].
GREMLICH, S ;
PORRET, A ;
HANI, EH ;
CHERIF, D ;
VIONNET, N ;
FROGUEL, P ;
THORENS, B .
DIABETES, 1995, 44 (10) :1202-1208
[8]   STIMULATION OF CLONED HUMAN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXPRESSED IN HEK-293 CELLS INDUCES CAMP-DEPENDENT ACTIVATION OF CALCIUM-INDUCED CALCIUM-RELEASE [J].
GROMADA, J ;
RORSMAN, P ;
DISSING, S ;
WULFF, BS .
FEBS LETTERS, 1995, 373 (02) :182-186
[9]   GLUCAGON-LIKE PEPTIDE-I INCREASES CYTOPLASMIC CALCIUM IN INSULIN-SECRETING BETA-TC3-CELLS BY ENHANCEMENT OF INTRACELLULAR CALCIUM MOBILIZATION [J].
GROMADA, J ;
DISSING, S ;
BOKVIST, K ;
RENSTROM, E ;
FROKJAERJENSEN, J ;
WULFF, BS ;
RORSMAN, P .
DIABETES, 1995, 44 (07) :767-774
[10]   Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas [J].
Gutniak, MK ;
Guenifi, A ;
Berggren, LJ ;
Holst, JJ ;
Hellstrom, PM ;
Efendic, S .
DIABETES CARE, 1996, 19 (08) :857-863